Eloquest Healthcare, Inc. is a wholly owned subsidiary of Ferndale Pharma Group, Inc. that is focused specifically on serving hospitals, their healthcare practitioners, and patients. Eloquest Healthcare helps deliver safer, more compassionate care by providing intuitive, cost-effective solutions that aid in the prevention of hospital acquired infections.
3 Questions with Michael Stern, MD “3 Questions With…” is a video series showcasing thought leaders in healthcare specialties like Infection Prevention and Vascular Access. These experts provide insights, evidence, and best practices in response to pressing questions in their fields. Eloquest Healthcare is proud to feature 3 Questions with Michael Stern, MD. In this…
3 Questions with Moira McErlean BSN, RN, VA-BC “3 Questions With…” is a video series showcasing thought leaders in healthcare specialties like Infection Prevention and Vascular Access. These experts provide insights, evidence, and best practices in response to pressing questions in their fields. Eloquest Healthcare is proud to feature 3 Questions with Moira McErlean, BSN,…
The STICKY Trial and the Impact of Gum Mastic Liquid Adhesive — An Interview with Dr. Nicole Marsh In this brief interview, Dr. Nicole Marsh, RN, MAdvPrac, PhD, discusses her award-winning randomized controlled trial, “Securing Jugular Central Venous Catheters With Dressings Fixed to a Liquid Adhesive to Prevent Dressing Failure in Intensive Care Patients (the…
3 Questions with Kacey Wiseman MSN, RN, CPN, VA-BC “3 Questions With…” is a video series showcasing thought leaders in healthcare specialties like Infection Prevention and Vascular Access. These experts provide insights, evidence, and best practices in response to pressing questions in their fields. Eloquest Healthcare is proud to feature 3 Questions with Kacey Wiseman…
Using Advanced Securement Devices to Decrease Risks to Patient Safety: New Research When it comes to vascular access devices (VADs), securement is more than a technical detail—it is the foundation of safe and effective care. For nurses at the frontlines of care, catheter dislodgement looms large as a constant risk—threatening device failure, delays in care,…
ECRI’s Focus on MARSI: Safer Solutions for Adhesive Challenges Medical adhesive-related skin injuries (MARSI) are more than a minor inconvenience. They are a prominent concern, highlighted by ECRI’s 2025 Health Technology Hazards report, which identifies MARSI as a significant issue in patient safety.1 Medical adhesives are essential for securing medical devices like vascular access devices,…
The Adhesive Advantage: How Gum Mastic Transformed Dressing Integrity and Reduced CLABSI Risk Hospital-acquired infections like central line-associated bloodstream infections (CLABSIs) can have devastating consequences. For one large trauma center, rising CLABSI rates in early 2023 signaled an urgent need for action. Despite rigorous training, checklist protocols, and staff education, the problem persisted. The turning…
3 Questions with Nancy Trick, RN, CRNI, VA-BC “3 Questions With…” is a video series showcasing thought leaders in healthcare specialties like Infection Prevention and Vascular Access. These experts provide insights, evidence, and best practices in response to pressing questions in their fields. Eloquest Healthcare is proud to feature 3 Questions with Nancy Trick, RN,…
As 2024 comes to a close, we would like to thank you for reading the Eloquest Healthcare Blog! We hope you have found our posts during the last 12 months to be both informative and impactful to your professional career. Here are some of the past year’s most liked posts that we invite you to…
Small Change, Big Impact: Mastisol® Added to a Central Line Dressing Protocol A podium poster presentation at the 2024 Association of Vascular Access Annual Scientific Meeting described noteworthy time savings for the Vascular Access Team (VAT) at the Mayo Clinic in Jacksonville, Florida. The authors, Zachary Lassiter, BSN, RN, Marisa Brown, BSN, RN, and Charles…
